Literature DB >> 10403438

Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.

S Modric1, A I Webb, M Davidson.   

Abstract

BACKGROUND AND
PURPOSE: In rats, murine respiratory mycoplasmosis is caused by Mycoplasma pulmonis. Tilmicosin, a macrolide antibiotic, has good tissue penetration and reaches high concentration in the lungs. Therefore, a model for studying the effects of disease on pharmacokinetics of tilmicosin was developed, using LEW rats.
METHODS: Seventy-two LEW rats were assigned at random to two groups: one group was inoculated with M. pulmonis, and the other served as an uninoculated control group. On postinoculation day 31, all rats received a single dose of tilmicosin (20 mg/kg of body weight, subcutaneously).
RESULTS: Concentration of tilmicosin in the lungs of both groups of rats was significantly higher than serum tilmicosin concentration at all times. Infected rats had significantly higher lung tilmicosin concentration than did noninfected rats. No correlation was found between pH of the lungs and tilmicosin concentration in the lungs in either treatment group, nor did treatment have any effect on pH of the muscle.
CONCLUSION: Tilmicosin accumulates in the lungs, and infection/inflammation further improves its tissue penetration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403438

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens.

Authors:  E A Abu-Basha; N M Idkaidek; A F Al-Shunnaq
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

2.  Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with Haemophilus parasuis.

Authors:  Ling Zhang; Li Zhao; Yonghong Liu; Junfeng Liu; Xianqiang Li
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

Review 3.  Respiratory diseases of rodents and rabbits.

Authors:  G P Langan; J J Lohmiller; S P Swing; C L Wardrip
Journal:  Vet Clin North Am Small Anim Pract       Date:  2000-11       Impact factor: 2.093

4.  Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies.

Authors:  Luyan Zhu; Xiaoxia Cao; Qinxin Xu; Jing Su; Xihe Li; Wenzhong Zhou
Journal:  Int J Nanomedicine       Date:  2018-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.